A surrogate endpoint.... The FDA instituted its
Post# of 147885
(Total Views: 352)
Posted On: 11/04/2024 11:02:28 PM
Quote:
A surrogate endpoint....
The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint.
In the case of mssCRC and Alzheimer's it would be proof in clinical endpoints backed up by surrogate endpoints. What would hinder mssCRC is unmet need.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼